Logo image of FNA

PARAGON 28 INC (FNA) Stock Fundamental Analysis

NYSE:FNA - New York Stock Exchange, Inc. - US69913P1057 - Common Stock - Currency: USD

13.09  0 (0%)

After market: 13.11 +0.02 (+0.15%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FNA. FNA was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While FNA seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, FNA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year FNA has reported negative net income.
In the past year FNA has reported a negative cash flow from operations.
In the past 5 years FNA reported 4 times negative net income.
In the past 5 years FNA reported 4 times negative operating cash flow.
FNA Yearly Net Income VS EBIT VS OCF VS FCFFNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -18.79%, FNA perfoms like the industry average, outperforming 52.36% of the companies in the same industry.
FNA has a Return On Equity of -41.84%. This is comparable to the rest of the industry: FNA outperforms 53.40% of its industry peers.
Industry RankSector Rank
ROA -18.79%
ROE -41.84%
ROIC N/A
ROA(3y)-19.77%
ROA(5y)-12.48%
ROE(3y)-38.84%
ROE(5y)-23.97%
ROIC(3y)N/A
ROIC(5y)N/A
FNA Yearly ROA, ROE, ROICFNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

FNA has a better Gross Margin (74.75%) than 86.91% of its industry peers.
FNA's Gross Margin has declined in the last couple of years.
FNA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.62%
GM growth 5Y-1.89%
FNA Yearly Profit, Operating, Gross MarginsFNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

FNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FNA has more shares outstanding
The number of shares outstanding for FNA has been increased compared to 5 years ago.
FNA has a worse debt/assets ratio than last year.
FNA Yearly Shares OutstandingFNA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
FNA Yearly Total Debt VS Total AssetsFNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 4.18 indicates that FNA is not in any danger for bankruptcy at the moment.
FNA has a Altman-Z score of 4.18. This is in the better half of the industry: FNA outperforms 76.44% of its industry peers.
A Debt/Equity ratio of 0.84 indicates that FNA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.84, FNA is not doing good in the industry: 72.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 4.18
ROIC/WACCN/A
WACC9.36%
FNA Yearly LT Debt VS Equity VS FCFFNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.51 indicates that FNA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.51, FNA is in the better half of the industry, outperforming 60.21% of the companies in the same industry.
A Quick Ratio of 1.64 indicates that FNA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.64, FNA is in line with its industry, outperforming 41.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 1.64
FNA Yearly Current Assets VS Current LiabilitesFNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for FNA have decreased strongly by -10.53% in the last year.
FNA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.39%.
Measured over the past years, FNA shows a quite strong growth in Revenue. The Revenue has been growing by 19.23% on average per year.
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y20.2%
Revenue growth 5Y19.23%
Sales Q2Q%18.47%

3.2 Future

The Earnings Per Share is expected to grow by 8.91% on average over the next years. This is quite good.
FNA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.63% yearly.
EPS Next Y25.22%
EPS Next 2Y21.57%
EPS Next 3Y6.22%
EPS Next 5Y8.91%
Revenue Next Year14.16%
Revenue Next 2Y14.04%
Revenue Next 3Y18.74%
Revenue Next 5Y18.63%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
FNA Yearly Revenue VS EstimatesFNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
FNA Yearly EPS VS EstimatesFNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FNA. In the last year negative earnings were reported.
Also next year FNA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FNA Price Earnings VS Forward Price EarningsFNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FNA Per share dataFNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.57%
EPS Next 3Y6.22%

More info and screens

0

5. Dividend

5.1 Amount

FNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARAGON 28 INC

NYSE:FNA (4/17/2025, 8:20:50 PM)

After market: 13.11 +0.02 (+0.15%)

13.09

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-08 2025-05-08/amc
Inst Owners56.68%
Inst Owner Change-1.99%
Ins Owners15.11%
Ins Owner Change-15.06%
Market Cap1.10B
Analysts72
Price Target14.28 (9.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.65%
Min EPS beat(2)-6.82%
Max EPS beat(2)5.52%
EPS beat(4)2
Avg EPS beat(4)-11.35%
Min EPS beat(4)-44.11%
Max EPS beat(4)5.52%
EPS beat(8)3
Avg EPS beat(8)-27.56%
EPS beat(12)3
Avg EPS beat(12)-39.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.3%
Max Revenue beat(2)1.87%
Revenue beat(4)4
Avg Revenue beat(4)1.03%
Min Revenue beat(4)0.3%
Max Revenue beat(4)1.87%
Revenue beat(8)7
Avg Revenue beat(8)0.91%
Revenue beat(12)11
Avg Revenue beat(12)2.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.1%
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.29
P/FCF N/A
P/OCF N/A
P/B 8.41
P/tB 12.96
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS3.05
BVpS1.56
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.79%
ROE -41.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.75%
FCFM N/A
ROA(3y)-19.77%
ROA(5y)-12.48%
ROE(3y)-38.84%
ROE(5y)-23.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.62%
GM growth 5Y-1.89%
F-Score2
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.39%
Cap/Sales 6.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.51
Quick Ratio 1.64
Altman-Z 4.18
F-Score2
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)195.19%
Cap/Depr(5y)198.62%
Cap/Sales(3y)14.44%
Cap/Sales(5y)13.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
EPS Next Y25.22%
EPS Next 2Y21.57%
EPS Next 3Y6.22%
EPS Next 5Y8.91%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y20.2%
Revenue growth 5Y19.23%
Sales Q2Q%18.47%
Revenue Next Year14.16%
Revenue Next 2Y14.04%
Revenue Next 3Y18.74%
Revenue Next 5Y18.63%
EBIT growth 1Y-9.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.67%
EBIT Next 3Y35.33%
EBIT Next 5Y30.86%
FCF growth 1Y52.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.51%
OCF growth 3YN/A
OCF growth 5YN/A